Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.50 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.50 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.49 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.49 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.49 |
| ▸ | GRM8 | O00222 | 1/20 | 0.48 |
| ▸ | GRM6 | O15303 | 1/20 | 0.48 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.48 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.48 |
| ▸ | GSR | P00390 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.48 |
| ▸ | GRM5 | P41594 | 1/20 | 0.48 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.48 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.48 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30099544 | 1.00 | DPP4 (0.50) | DPP4DPP8DPP9FOLH1RIMKLA | |
| SCHEMBL30099651 | 1.00 | DPP4 (0.50) | DPP4DPP8DPP9FOLH1RIMKLA | |
| SCHEMBL30099554 | 1.00 | DPP4 (0.50) | DPP4DPP8DPP9FOLH1RIMKLA | |
| SCHEMBL30099498 | 1.00 | DPP4 (0.50) | DPP4DPP8DPP9FOLH1RIMKLA | |
| SCHEMBL31453847 | 1.00 | DPP4 (0.50) | DPP4DPP8DPP9FOLH1RIMKLA | |
| SCHEMBL31448323 | 0.97 | FOLH1 (0.53) | DPP4DPP8DPP9FOLH1RIMKLA | |
| SCHEMBL30607422 | 0.97 | FOLH1 (0.53) | DPP4DPP8DPP9FOLH1RIMKLA | |
| SCHEMBL31287182 | 0.97 | DPP4 (0.53) | DPP4DPP8DPP9FOLH1RIMKLA | |
| SCHEMBL28482649 | 0.97 | DPP4 (0.53) | DPP4DPP8DPP9FOLH1RIMKLA | |
| SCHEMBL29379253 | 0.97 | DPP4 (0.53) | DPP4DPP8DPP9FOLH1RIMKLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514939-B2 | Stable radiopharmaceutical compositions and uses thereof | ALPHA-9 ONCOLOGY, INC. (CA) | 2026-01-06 | — | — | US | disclosed |
| US-20250255993-A1 | STABLE RADIOPHARMACEUTICAL COMPOSITIONS AND USES THEREOF | ALPHA-9 ONCOLOGY INC. (CA) | 2025-08-14 | — | — | US | disclosed |
| CN-112125821-B | Aqueous solution containing N-long-chain acyl acidic amino acid and/or salt thereof and method for producing same | 味之素株式会社 | 2024-02-20 | — | — | CN | disclosed |
| CN-116004221-B | New application of cyclic peptide, acridine labeled complex, preparation method and detection kit | 湖南卓润生物科技有限公司 | 2023-12-19 | — | — | CN | disclosed |
| CN-116004221-A | New application of cyclic peptide, acridine labeled complex, preparation method and detection kit | 湖南卓润生物科技有限公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-115261317-A | Method for culturing cells, and kit and apparatus for the same | 朱诺治疗学有限公司 | 2022-11-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250255993-A1 | STABLE RADIOPHARMACEUTICAL COMPOSITIONS AND USES THEREOF | RCN1, RABL6, QPCT | DPP4 4320/4885DPP8 4343/4885DPP9 4346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.